Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CID 0706 - Safety, Tolerability, Pharmacokinetic, and Metabolic Features of Raltegravir Among African-American Men and Women With HIV Infection

NCT00667433 is registered in ClinicalTrials.gov with David A Wohl, MD as lead sponsor.

NCT NCT00667433
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00667433 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CID 0706 - Safety, Tolerability, Pharmacokinetic, and Metabolic Features of Raltegravir Among African-American Men and Women With HIV Infection
Lead sponsor
David A Wohl, MD
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2008
Completion date
December 31, 2011
Enrollment
38 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections